{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:09:23Z","timestamp":1788977363329,"version":"build-2803163510"},"reference-count":48,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutical Development and Technology"],"published-print":{"date-parts":[[2026,7,3]]},"DOI":"10.1080\/10837450.2026.2707519","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:28:09Z","timestamp":1784723289000},"page":"1050-1070","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Taste-Masked orodispersible tablets of alfuzosin hydrochloride: response surface methodology (RSM) based approach for enhanced patient compliance in BPH management"],"prefix":"10.1080","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5937-4343","authenticated-orcid":false,"given":"Majid","family":"Imam","sequence":"first","affiliation":[{"name":"Amity Institute of Pharmacy, Amity University Uttar Pradesh","place":["Noida, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8410-5901","authenticated-orcid":false,"given":"Neeraj","family":"Gupta","sequence":"additional","affiliation":[{"name":"Amity Institute of Pharmacy, Amity University Uttar Pradesh","place":["Noida, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1945-4808","authenticated-orcid":false,"given":"Somesh","family":"Narayan","sequence":"additional","affiliation":[{"name":"Amity Institute of Pharmacy, Amity University Uttar Pradesh","place":["Noida, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0790-784X","authenticated-orcid":false,"given":"Kalpana","family":"Nagpal","sequence":"additional","affiliation":[{"name":"Amity Institute of Pharmacy, Amity University Uttar Pradesh","place":["Noida, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.17112685"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.2012.01473.x"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.22214\/ijraset.2025.70965"},{"issue":"9","key":"e_1_3_7_5_1","first-page":"01","article-title":"Formulation and evaluation of diclofenac orodispersible tablets","volume":"10","author":"Alburyhi MM","year":"2023","unstructured":"Alburyhi MM, Saif AA, Noman MA, Saeed SA, Al-Ghorafi MA. 2023. Formulation and evaluation of diclofenac orodispersible tablets. Eur J Pharm Med Res. 10(9):01\u201306.","journal-title":"Eur J Pharm Med Res"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2010.03.012"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S515139"},{"issue":"2","key":"e_1_3_7_8_1","first-page":"508","article-title":"Review of the use of croscarmellose sodium and crospovidone superdisintegrants in orally disintegrating tablets (ODT)","volume":"22","author":"Antari ED","year":"2021","unstructured":"Antari ED, Kuncahyo I, Sulaiman TN. 2021. Review of the use of croscarmellose sodium and crospovidone superdisintegrants in orally disintegrating tablets (ODT). International Journal of Pharmacy & Pharmaceutical Research. 22(2):508\u2013519.","journal-title":"International Journal of Pharmacy & Pharmaceutical Research"},{"issue":"4","key":"e_1_3_7_9_1","first-page":"2324","article-title":"Drug release kinetics and comparative study of oxaprozin nonogel with market formulation","volume":"15","author":"Bhardwaj S","year":"2024","unstructured":"Bhardwaj S, Kalra N, Khan W. 2024. Drug release kinetics and comparative study of oxaprozin nonogel with market formulation. Int J Pharm Qual Assur. 15(4):2324\u20132329.","journal-title":"Int J Pharm Qual Assur"},{"issue":"2","key":"e_1_3_7_10_1","first-page":"80","article-title":"A review on formulation and evaluation of orodispersible tablets","volume":"13","author":"Bhatt A.","year":"2023","unstructured":"Bhatt A. 2023. A review on formulation and evaluation of orodispersible tablets. Int J Pharm Biol Sci. 13(2):80\u201392.","journal-title":"Int J Pharm Biol Sci"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bfopcu.2016.12.001"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-014-0137-4"},{"key":"e_1_3_7_13_1","first-page":"317","volume-title":"Handbook of Pharmaceutical Wet Granulation","author":"D\u00fcrig T","year":"2019","unstructured":"D\u00fcrig T, Karan K. 2019. Binders in wet granulation. In Handbook of Pharmaceutical Wet Granulation. Elsevier; p. 317\u201349."},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.21276\/irjps.2017.4.1.3"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v9i3-s.2950"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6618934"},{"issue":"5","key":"e_1_3_7_17_1","first-page":"602","article-title":"Formulation design and optimization of mouth dissolve tablets","volume":"66","author":"Gohel M","year":"2004","unstructured":"Gohel M, Patel M, Amin A et al. 2004. Formulation design and optimization of mouth dissolve tablets. Indian J Pharm Sci. 66(5):602\u2013607.","journal-title":"Indian J Pharm Sci"},{"key":"e_1_3_7_18_1","unstructured":"Google Patents. 2016. Tablet comprising crospovidone (US20160193153A1). Available from: https:\/\/patents.google.com\/patent\/US20160193153A1\/en"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s44199-024-00093-9"},{"key":"e_1_3_7_20_1","unstructured":"Indian Pharmacopoeia Commission. Disintegration test. Available from. https:\/\/www.ipc.gov.in\/images\/pdf\/Disintegration_Test-0627347746.pdf"},{"issue":"4","key":"e_1_3_7_21_1","first-page":"3098","article-title":"Microcrystalline Cellulose in Pharmaceutical Formulations: a Comprehensive Review on Applications, Concentrations, And Functional Attributes","volume":"3","author":"Janvalkar M","year":"2025","unstructured":"Janvalkar M, Kaloji P, Shettigar R. 2025. Microcrystalline Cellulose in Pharmaceutical Formulations: a Comprehensive Review on Applications, Concentrations, And Functional Attributes. International Journal of Pharmaceutical Sciences. 3(4):3098\u20133112.","journal-title":"International Journal of Pharmaceutical Sciences"},{"issue":"3","key":"e_1_3_7_22_1","first-page":"127","article-title":"Applications of ion exchange resin in oral drug delivery systems","volume":"7","author":"Kathpalia H","year":"2017","unstructured":"Kathpalia H, Das S. 2017. Applications of ion exchange resin in oral drug delivery systems. Int J Drug Deliv Technol. 7(3):127\u2013136.","journal-title":"Int J Drug Deliv Technol"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106965"},{"issue":"3","key":"e_1_3_7_24_1","first-page":"1068","article-title":"Formulation and evaluation of hydralazine hydrochloride mouth dissolving tablet for the management of eclampsia and pre-eclampsia","volume":"9","author":"Kumar SM","year":"2018","unstructured":"Kumar SM, Ganapathy RS. 2018. Formulation and evaluation of hydralazine hydrochloride mouth dissolving tablet for the management of eclampsia and pre-eclampsia. Int J Pharm Sci Res. 9(3):1068\u20131076.","journal-title":"Int J Pharm Sci Res"},{"issue":"09","key":"e_1_3_7_25_1","first-page":"161","article-title":"Formulation and evaluation of oral disintegrated tablets of Alfuzosin Hydrochloride using superdisintegrants","volume":"01","author":"Leela MK","year":"2011","unstructured":"Leela MK, Ramana G, Digpati R. 2011. Formulation and evaluation of oral disintegrated tablets of Alfuzosin Hydrochloride using superdisintegrants. J Appl Pharm Sci. 01(09):161\u2013165.","journal-title":"J Appl Pharm Sci"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ipha.2024.01.011"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756287221993283"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.05.017"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.4103\/0975-1483.100021"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2012.08.035"},{"issue":"4","key":"e_1_3_7_31_1","first-page":"1806","article-title":"Formulation and in vitro evaluation of mouth dissolving tablets of daclatasvir dihydrochloride","volume":"10","author":"Pakalapati P","year":"2021","unstructured":"Pakalapati P, Dhonipudi SV, Kondeti SB. 2021. Formulation and in vitro evaluation of mouth dissolving tablets of daclatasvir dihydrochloride. World J Pharm Res. 10(4):1806\u20131858.","journal-title":"World J Pharm Res"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/pr7110779"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2010.08.025"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.69613\/vx91cb41"},{"key":"e_1_3_7_35_1","first-page":"84","article-title":"Formulation and evaluation of orodispersible tablets of alfuzosin","volume":"2","author":"Raju SA","year":"2010","unstructured":"Raju SA et al. 2010. Formulation and evaluation of orodispersible tablets of alfuzosin. Int J Pharmtech Res. 2:84\u201388.","journal-title":"Int J Pharmtech Res"},{"key":"e_1_3_7_36_1","article-title":"Formulation and evaluation of oral disintegrated tablets of alfuzosin hydrochloride using superdisintegrants","volume":"161","author":"Ramana G","year":"2011","unstructured":"Ramana G, Roy D. 2011. Formulation and evaluation of oral disintegrated tablets of alfuzosin hydrochloride using superdisintegrants. J Appl Pharm Sci. 161-5.","journal-title":"J Appl Pharm Sci"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-012-9835-y"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101942"},{"issue":"5","key":"e_1_3_7_39_1","first-page":"6","article-title":"Formulation and evaluation of an orodispersible tablet of empagliflozin using a natural super-disintegrating agent","volume":"7","author":"Shirsekar P","year":"2024","unstructured":"Shirsekar P, Chowdhary S, Waikar A, Pawar S, Yadav B. 2024. Formulation and evaluation of an orodispersible tablet of empagliflozin using a natural super-disintegrating agent. Int Res J Pharm Med Sci. 7(5):6\u201311.","journal-title":"Int Res J Pharm Med Sci"},{"issue":"5","key":"e_1_3_7_40_1","first-page":"6","article-title":"Formulation and evaluation of an orodispersible tablet of empagliflozin using a natural super-disintegrating agent","volume":"7","author":"Shirsekar P","year":"2024","unstructured":"Shirsekar P, Chowdhary S, Waikar A, Pawar S, Yadav B. 2024. Formulation and evaluation of an orodispersible tablet of empagliflozin using a natural super-disintegrating agent. International Research Journal of Pharmacy and Medical Sciences (IRJPMS). Volume 7Issue(5):6\u201311.","journal-title":"International Research Journal of Pharmacy and Medical Sciences (IRJPMS)"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ipha.2023.06.006"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.06.055"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2016.09.056"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40005-023-00647-6"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-022-02266-0"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2014.02.012"},{"key":"e_1_3_7_47_1","unstructured":"World Intellectual Property Organization. Pharmaceutical Formulations Comprising Magnesium Stearate (WO2005004845A1). 2004. Available from: https:\/\/patents.google.com\/patent\/WO2005004845A1\/en"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24544"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10030157"}],"container-title":["Pharmaceutical Development and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10837450.2026.2707519","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/10837450.2026.2707519","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10837450.2026.2707519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:38:20Z","timestamp":1788975500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10837450.2026.2707519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,7,3]]}},"alternative-id":["10.1080\/10837450.2026.2707519"],"URL":"https:\/\/doi.org\/10.1080\/10837450.2026.2707519","relation":{},"ISSN":["1083-7450","1097-9867"],"issn-type":[{"value":"1083-7450","type":"print"},{"value":"1097-9867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iphd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-05-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}